Skip to main content
. 2015 May 15;5:95. doi: 10.3389/fonc.2015.00095

Figure 4.

Figure 4

CK2i of the drug resistant cell line (LM-MEL-28-R1). The effects of co-inhibition with the CK2 inhibitor CX-4945 and BRAFi (PLX4072) on proliferation of the drug resistant cell population LM-MEL-28-R1 were quantitated by viability assay, analyzed using a Student’s t-test (error bars are SD).